Skip to content
OpenCapital
Get started

Lovesac LOVE Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

HTF
Heartflow, Inc. Common StockHTFL
$15.41M-25.5%
Photronics logo
PhotronicsPLAB
$3.9M+43.5%
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$756K-37.7%
KEE
Keel Infrastructure Corp. Common StockKEEL
$2.19M-50.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$7.96M-63.4%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$6.19M-79.2%

Other financials

Income statement

See full
Revenue$138.2M-0.1%
Gross profit$72.0M-3.2%
Operating income-$17.4M-16.2%
Net income-$11.1M-2.3%
EPS (diluted)-$0.76-4.1%

Balance sheet

See full
Cash & equivalents$57.0M+112%
Total debt$190.9M-0.4%
Total equity$205.5M+2.1%
Total assets$501.0M+3.6%

Cash flow

See full
Operating cash flow-$35.4M+14.6%
CapEx$5.0M-41.4%
Free cash flow-$40.4M+19.2%

Valuation

See full
Market cap$244.32M-8.7%
Enterprise value$378.19M-12.5%
P/E64.1×+44.5×
P/S0.4×0.0×

Profitability

See full
Gross margin56.1%-2.2pp
Operating margin0.4%-2.0pp
Net margin0.5%-1.4pp
FCF margin5.1%+3.8pp

Returns & leverage

See full
Return on equity1.9%-4.9pp
Debt / equity0.9×0.0×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Lovesac in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment.

The official record: Lovesac’s 10-K, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lovesac's indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lovesac's indefinite-lived research and development assets?
Lovesac (LOVE) reported indefinite-lived research and development assets of $2.09M in Q4 2025.
How has Lovesac's indefinite-lived research and development assets changed year-over-year?
Lovesac's indefinite-lived research and development assets decreased by 50.0% year-over-year, from $4.18M to $2.09M.
What does indefinite-lived research and development assets mean?
These are acquired research and development assets that are not yet amortized because they have not reached a stage of commercial viability. They represent the company's investment in future product pipelines and long-term innovation potential. Changes in this balance indicate the progress or impairment of strategic R&D initiatives.